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ABSTRACT
Purpose Bolus injection of fluid into subcutaneous tissue
results in accumulation of fluid at the injection site. The fluid
does not form a pool. Rather, the injection pressure forces the
interstitial matrix to expand to accommodate the excess fluid
in its volume, and the fluid becomes bound similar to that in a
hydrogel. We seek to understand the properties and dynamics
of externally tumesced (swollen) subcutaneous tissue as a first
step in assessing whether tumescent antibiotic injections into
wounds may provide a novel method of treatment.
Methods Subcutaneous injections of saline are performed in
live and dead pigs and the physical properties (volume, expan-
sion ratio, residence time, apparent diffusion constant) of the
resulting fluid deposits are observed with diffusion-weighted
magnetic resonance imaging, computed tomography, and 3D
scanning.
Results Subcutaneous tissue can expand to a few times its
initial volume to accommodate the injected fluid, which is
dispersed thoroughly throughout the tumescent volume. The
fluid spreads to peripheral unexpanded regions over the
course of a few minutes, after which it remains in place for
several hours. Eventually the circulation absorbs the excess
fluid and the tissue returns to its original state.
Conclusions Given the evidence for dense fluid dispersal and
several-hour residence time, a procedure is proposed whereby
tumescent antibiotic injections are used to treat drug-resistant
skin infections and chronic wounds that extend into the sub-
cutaneous tissue. The procedure has the potential to effective-
ly treat otherwise untreatable wounds by keeping drug con-
centrations above minimum inhibitory levels for extended
lengths of time.
KEY WORDS antibiotic injections . antibiotic resistant
wounds . chronic wounds . hydraulic permeability of
subcutaneous tissue . pig subcutaneous tissue . subcutaneous
injections . tumescent Injections . tumescent tissue
INTRODUCTION
In this research article, we describe physics experiments on the
in-vivo hydraulic permeability of subcutaneous pig tissue that
has been tumesced (swelled) by an external injection. Our goal
is to provide data that helps answer the question: can skin
infections and chronic wounds be treated with targeted anti-
biotic injections? If concentrated antibiotic is infused into the
tissue directly underneath an infected wound, will it cure the
infection? The chief advantage of local treatment is that drugs
can be delivered directly to the affected regions at higher
concentration with reduced risk of systemic toxicity, making
them particularly attractive for treating antibiotic-resistant
infections [1]. Topical antimicrobial therapy for chronic
wounds remains unproven despite tremendous effort in this
direction [2].We demonstrate below that tumescent injections
into healthy subcutaneous tissue go beyond a surface
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treatment by infusing fluid in a way that causes it to complete-
ly permeate the tissue volume.
Antibiotic injections are not a standard method of wound
care, and there is a void in the literature on the topic. One
explanation, is that the procedure does not work, or that it is
dangerous. For instance, some antibiotics may be toxic to
tissue at elevated concentrations. Particularly worrisome is
the risk of spreading the infection as the fluid disperses. Will
the risk of spreading the injection be reduced if the fluid is a
concentrated antibiotic? Even if the injection is safe in itself, if
the antibiotic is absorbed rapidly by the circulation, the net
effect of the injection is equivalent to a systemic dose, and the
benefits of a local treatment are lost. We demonstrate below
that fluid remains in the tumesced tissue near the injection site
for many hours.
The medical questions which drive our physics-based
experiments are motivated by the work of Jeffrey Klein and
Barry Silberg. Jeffrey Klein invented the tumescent technique
in the late 1980s as an alternative method of liposuction [3, 4],
that has since proven itself a safe, low-complications proce-
dure and become common practice [5]. Under this proce-
dure, up to several liter of saline with additives are infused
into subcutaneous tissue, causing it to swell and expand, be-
fore a suction cannula is inserted and fat is removed. Despite
the trauma of the expansion, the tissue heals on its own [5].
Nowadays, the technique is used more broadly for cosmetic,
vascular, orthopedic, and other procedures [6, 7]. Barry
Silberg uses tumescent antibiotic injections supplemented by
transcutaneous therapeutic ultrasound to treat soft skin and
tissue pathologies [8]. The injection and ultrasound combina-
tion has successfully treated 94 patients under an institutional-
review-board-approved phase 1 study [9], including many
with drug-resistant infections. Despite injecting large volumes
of fluid directly into and underneath infections, not a single
case of infection spreading was reported. Tumescent antibiot-
ic injections without externally applied ultrasound have not
been reported.
Tumescent injections are performed by inserting a needle
or cannula into subcutaneous tissue and infusing sufficient
volumes of fluid at a fast enough rate to deliberately cause
swelling [4]. This is distinguished from subcutaneous admin-
istration of biotherapeutics or antibiotics and hypodermoclysis
(HDC), where care is taken to avoid swelling. HDC is becom-
ing a popular method of hydrating geriatric patients due to its
simplicity and safety, where liters of fluids, usually saline, are
infused at a rate of about 1–2.5 mL min−1 for many hours
[10–13]. These infusion rates are chosen to be slow enough
that the infusate is dispersed before it can accumulate and
cause swelling. Similar infusion rates are used when adminis-
tering biotherapeutics or antibiotics subcutaneously (but not
tumescently) as an alternative to the intravenous (IV) route
[14]. As the non-tumescent subcutaneous route is used as an
alternative for systemic delivery, research on it has focused on
the altered pharmacokinetics, pharmacodynamics, and bio-
availability [15–24], not on its potential for localized treatment.
Tumescent infusions are done 10–100× faster, with total vol-
umes ranging between 0.1–2 L, depending on the surface area
to be covered.
This work investigates the properties and dynamics of the
tumescent tissue subsequent to the injection. We use various
methods to monitor the fluid infused into the healthy subcu-
taneous tissue of live and dead pigs, including diffusion-
weighted magnetic resonance imaging (DW-MRI), computed
tomography (CT), and 3D scanning. The use of animals was
approved by the Animal Research Committee in accordance
with accepted national standards and guidelines (Institutional
Review Board Number 2014–142-03). Pigs used were part of
an unrelated research project and no animal was sacrificed as
part of this work. Our key findings are that 1) subcutaneous
tissue can expand >3× to accommodate the fluid, which 2)
becomes densely distributed throughout the volume of the
subcutaneous tissue, and 3) remains localized for many hours.
There are two distinct timescales of fluid dispersal: one is a
localized spreading within the subcutaneous tissue itself that
occurs over a few minutes, and the other is slow systemic
absorption via the circulation over many hours. In light of
these experimental insights, we end by proposing a hypothet-
ical clinical procedure whereby tumescent injections of anti-
biotics are used to treat deep chronic wounds that extend past
the dermis.
DILATION OF SUBCUTANEOUS TISSUE
A 10 mL tumescent injection of blue-dyed saline into a dead
Yucatán minipig leaves a bleb about 4 cm across, and 1 cm
thick (Fig. 1a). Slicing into it allows visual confirmation of the
dispersal density and quality. The fluid gets trapped within the
extracellular matrix, and forces it to expand to several times its
initial volume. Figure 1b shows an expansion of about 4× in
the subcutaneous tissue of a dead Yorkshire pig, transforming
it from soft and opaque, to translucent and firm. We know of
no synthetic material of similar density that can dilate by such
a large factor without cracking. The same experiment in gel-
atin, for instance, creates a crack whose leading edge propa-
gates as more fluid is injected [25, 26].
Investigations of the fine structure of small volume
(<0.5 mL) injection sites with X-rays [27] and cryomicrotome
microscopy [28] have revealed that the fluid opens channels
between adipose cells as it searches for the path of least resis-
tance. These channels propagate and expand as more volume
is infused in a process similar to the hydraulic fracture of rocks
[29]. As the tumescent volume expands, the extracellular ma-
trix stretches, opening up pores, and filling the extra volume
with the infusate. Histological samples of tumesced and nor-
mal tissue (Figs. 1c and 1d respectively, see supplementary
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methods) reveal the microscopic disruption of the tissue after a
5 mL injection.
In the tumesced state, tissue permeability dramatically
increases, enhancing fluid and additive dispersal. Indeed,
the hydraulic conductivity (Darcy permeability) of normal
subcutaneous tissue is low, about 10−11 cm4dyne−1sec−1
[30], but can increase by over four orders of magnitude
upon swelling [31]. This property allows visualization of
tumesced tissue with diffusion-weighted magnetic reso-
nance imaging (DW-MRI). DW-MRI is a non-invasive
method of measuring the apparent diffusion coefficient
(ADC) - a measure of the molecular diffusion of water -
within tissue [32]. We infused increasing volumes of saline
(0–40 mL) into both right and left thighs of an anesthetized
juvenile Yucatán pig, and DW-MRI was performed to
quantify the tumescent volume and mean ADC as a func-
tion of total fluid volume infused (see supplementary meth-
ods). Figure 2a is an axial, ADC map intersecting the tu-
mescent volume after 40 mL was infused. The ADC is
about 1.4 ·10−3mm2s −1 in the muscle underneath the tu-
mescent tissue, as seen in lineouts crossing the tumescent
region (Fig. 2b), consistent with the literature [33]. The
ADC saturates at a value consistent with the self-diffusion
coefficient of water, 2.5 ·10−3mm2s−1 [34], for even the
smallest injection performed, 5 mL. It appears that even
for such small injections, the tissue has expanded enough
where the structure of the interstitial matrix negligibly
restricts molecular diffusion. As more fluid is infused, the
tumescent volume expands both into the empty space
above the skin, but also into the body below; a small volume
of normal, unexpanded tissue swells to a larger volume. Not
shown, is that in addition to the thickness growing, the area
covered broadens as well. We define the average expansion
ratio to be the final tumescent volume divided by the initial,
pre-expansion volume. The total volume of the tumescent
region for a given volume injection gives a measure of the
average degree of expansion (Fig. 2c). For instance, when
20 mL were infused, the tumescent volume was 30 mL,
meaning that 10 mL of tissue expanded to 30 mL, and so
the average degree of expansion was 3× [28].
However, there is considerable variation in the degree of
expansion within the tumescent volume, as indicated by the
visible white streaks within the blue region in Fig. 1a. To
characterize the amount of variation, small samples (about
Fig. 1 Tumescent injections in pig
subcutaneous tissue. (a) Tumescent
injection of 10 mL saline (dyed blue)
causes a large, conspicuous bleb to
form in the skin of a dead Yucatán
pig, shown in the inset. Slicing into it
reveals that the liquid is held in the
subcutaneous tissue, which was
forced to expand to accommodate
the liquid. (b) Subcutaneous tissue
of a Yorkshire pig swells in propor-
tion to volume of injected saline,
reaching about 4× expansion in this
case. Histology of (d) normal and (c)
tumescent subcutaneous tissue of a
minipig after a 5 mL saline injection,
shown at the same scale.
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0.5 g each) were cut from the tumescent region, and weighed
before and after desiccation (see supplementary methods).
While taking samples, we attempted to avoid regions with
visible white streaks and focused instead on the more trans-
parent, high-expansion regions. The streaks were expanded as
well, but to a lesser degree. Consequently, the resulting data
should be interpreted as representative of local maxima in
expansion, not random samples. For the smaller volume injec-
tions, it was difficult to avoid the streaks embedded within the
tumescent volume andmore found their way into the samples.
The wet-to-dry-weight-ratio is shown in Fig. 2d for various
volumes injected, and is roughly proportional to volume
injected. Control samples, taken from regions without injec-
tion, have a wet-to-dry-weight-ratio of 1.7, while tissue
tumesced with 20 mL saline had regions with ratios of 10–
50, which implies an expansion of 6–30×.
LOCAL SPREADING
WITHIN THE INTERSTITIAL MATRIX OCCURS
OVER A FEW MINUTES
We observe distinct processes as the infused fluid dissipates
and the tissue returns to normal. Once the injection is com-
plete, a pressure gradient exists between the tumesced site and
the surrounding tissue that drives outwards flow confined
within the subcutaneous tissue. As the flowing fluid overtakes
more unexpanded tissue, the tumescent volume increases by
Fig. 2 Expansion of tumescent tissue characterized by Diffusion-Weighted MRI. Panel a) is an apparent diffusion coefficient (ADC) map showing an axial cross
section through the quadriceps of an adolescent Yucatán pig laying in a supine position after 40 mL physiological saline had been infused into the subcutaneous
tissue of both right and left thighs. Whiter regions correspond to higher ADC. Lineouts along the green line in a) are shown in b), as more liquid is infused into the
subcutaneous tissue. The tumescent volume and spatially averaged ADC are plotted in c). Uncertainty bars on the mean ADC plot indicate the standard deviation
of the ADC within the tumescent volume. Numbers next to volume curve markers are the average expansion ratio as calculated from the tumescent volume.
Expansion of subcutaneous tissue is also measured by surgically removing samples from within it, and weighing them before and after desiccation. Tumescent
tissue samples were chosen to represent maximal levels of expansion (as in the bluer regions of Fig. 1a) - they are not randomly selected. The wet-to-dry weight
ratio, and expansion ratio, are plotted in d). The scatter of the points with the same injection volume is characteristic of the spatial variations within the tumescent
volume.
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the amount of tissue overtaken and softens because the
injected fluid is spread over more tissue. This process occurs
over a few minutes and is observed in both live and dead pigs.
In live pigs, we also observe the circulation absorbing the fluid
and distributing it through the body on a multi-hour time-
scale, as discussed in the next section.
CT imaging allows tracking the 3D tumescent region over
time. Eight tumescent injections were made in the abdomen
of an anesthetized adult Yucatán pig, 2 each of 2.5, 5, 10, and
20 mL physiological saline solution containing dilute iodine
contrast and CT scans were taken every 5–10 min for 70 min
(see supplementary methods). Figure 3a displays three orthog-
onal views of a 20 mL injection immediately after the injec-
tion. Because the contrast increased the x-ray absorption of
the tumescent fluid, the tumescent region is easily discerned in
the image. The volume andmean attenuation within the tum-
esced regions were measured, and are displayed in Figs. 3b
and 3c respectively. Note that there is a rise in the tumescent
Fig. 3 Evolution of various volume tumescent injections over an hour as measured by CT. Panel (a) shows three orthogonal CT views of a 20 mL tumescent
injection into the abdomen of a live, adult Yucatán pig, viewed inmaximum-intensity-projection (MIP) mode. Green and blue lines indicate the center and extent of
the MIP slabs. The volume (b), and spatially averaged attenuation (c), are multiplied to produce the total contrast curve in (d).
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volume during the first 5–10 min, corresponding with a drop
in the mean attenuation, despite no additional fluid being
infused. This reflects the fluid spreading within the subcuta-
neous tissue, overtaking more unexpanded tissue, but staying
localized (not removed by lymph and/or blood circulation
[35]). Multiplying the mean attenuation by the volume gives
the total contrast curve in Fig. 3d, which is a measure of the
total amount of contrast near the injection site. If the contrast
was being taken away from the tumesced region by the circu-
lation, this curve would decrease, and so its initial flatness
confirms our localized spreading interpretation. On longer
timescales (discussed below), we do see absorption by the cir-
culation, as indicated by the slow decrease in the total contrast
curve. Once again we can estimate the average expansion by
comparing the mean attenuation within the tumesced tissue
(200–300 HU depending on the time after injection) to that in
normal subcutaneous tissue (−90 HU) and that in the pure
solution (500 HU), yielding average expansions of 2–3×, con-
sistent with our previous estimates.
We were able to isolate the localized spreading dynamics
from the systemic absorption by studying the evolution of the
tumescent skin profile in a dead pig, where there is no circu-
lation to distribute the injection through the body. A 20 mL
tumescent injection was performed in the abdomen of a dead
juvenile Yucatán, and 3D photographs were taken with a
Fuel-3D Scannify system periodically for 20 min to quantify
the shape of the bleb on the skin surface and its motion over
time (see supplementary methods). Figure 4a shows the raw
data before and immediately after injection. Note that the Z-
scale is 10× smaller than the X and Y scale. Lineouts along
X= 0 and Y = 0 are shown in Figs. 4b and 4c respectively for
various times after the injection. It is clear that the tumesced
volume changes shape very rapidly early on, droppingmore in
the first two minutes than in the subsequent seventeen. After
about 10 min, the changes are imperceptible. The contour
maps of Figs. 4e and 4f show the difference between the skin
profile before the injection and that at t = 0 or t = 19 min
respectively. Plotting the max difference (height) and cross-
sectional area at half-height over time gives Fig. 4d. The prod-
uct of the height and area curves (not shown), a quantity pro-
portional to the fluid volume injected, is constant within
uncertainties, indicating that no substantial fraction of the
fluid was removed from the injection site by systemic circula-
tion. In a live pig, when the local spreading slows enough, the
circulation becomes the dominant mechanism of further
distribution.
There is an open theoretical question of the expected
form of such a decay based on Darcy’s law in a medium
whose permeability depends on the degree of expansion.
Poroelastic models that couple flow and gel mechanics
[36–39] need to include nonlinear effects such as the re-
duced Darcy resistance in expanded regions if they seek to
accurately capture the observed dynamics. With nonlinear
modeling, it may be possible to back out the intrinsic per-
meability of subcutaneous tissue [37] from data such as that
presented in Fig. 4.
SYSTEMIC ABSORPTION OCCURS
OVER SEVERAL HOURS
Eventually the tumescent fluid dissipates and the interstitial
tissue returns to normal. This work is the first to measure the
dissipation timescale directly. Indirect estimates based on plas-
ma lidocaine concentrations following tumescent liposuction
[40] suggest that some infused fluid remains localized for
~10 hr. But tumescent fluid used for anesthesia usually con-
tains dilute epinephrine, a vasoconstrictor, to minimize blood
loss and slow down the rate of lidocaine absorption [41]. We
expect epinephrine would also extend the fluid residence time.
We performed CT scans periodically over seven hours to
observe the fluid dissipation both with and without epineph-
rine. As before, eight tumescent injections were made in the
abdomen of an anesthetized adult Yucatán pig, 2 each of 2.5,
5, 10, and 20 mL physiological saline solution containing di-
lute iodine contrast. A few weeks later, we performed the same
experiment on the same pig, with the addition of 1:100000
epinephrine to the tumescent solution (see supplementary
methods).
Coronal images in maximum-intensity-projection (MIP)
mode are shown in Figs. 5a and 5b without and with epineph-
rine respectively. In both cases, localized spreading occurs
between the t= 0 and the t= 0.5 hr images, as indicated by
the boundary of the tumescent region becoming less sharp;
epinephrine did not affect this. As time progresses, the contrast
fades away. Without epinephrine, it is hard to see any remain-
ing contrast after three hours. With epinephrine, it is easily
visible after seven hours. For a more precise comparison, we
took lineouts crossing the center of each spot, seen in Fig. 5c,
and plotted the peak value vs time in Fig. 5d. Attenuation
levels after six hours in the presence of epinephrine are com-
parable to those after half an hour without epinephrine.
However, even without epinephrine, the contrast remains
substantially localized for 2–3 hr for the larger injections. In
general, the larger injections decay slower.
APPLICATIONS TO CHRONIC WOUNDS,
SYSTEMIC DRUG DELIVERY
This work observed the localization and spreading of saline,
with contrast (CT), and without contrast (MRI, 3D scanning).
The data show that tumescent injections force the expansion
of subcutaneous tissue from the inside out, dilating the inter-
stitial matrix, and saturating it with fluid. Average expansion
ratios of 2− 4× are readily achievable, a factor high enough
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whereby the hydraulic resistance of the interstitial matrix is
greatly reduced. The fluid residence time is 2–3 hr without
any special preparation, and can be extended to well over 7 hr
with the use of epinephrine. Systemic circulation eventually
spreads the fluid to the entire body and the injection site
returns to normal. Although the spreading of drugs added to
the saline may be more complex due to, for example, cellular
uptake, changes in stability, and degradation, and will require
further study on a case-by-case basis, some general conclu-
sions may be drawn regarding the expected dynamics of
additives. Those that are small and stay in solution are
expected to spread in a similar manner to the saline. Larger
additives whose dimensions are comparable to or larger than
the expanded matrix pore size will be preferentially filtered
and remain localized longer. Take for example, the iohexol
molecule used as a contrast agent in the CT experiments. The
uniformity of the contrast in the tumescent volumes pictured
in Figs. 3 and 5, in particular the lack of iodine accumulation
near the injection site, suggests that the interstitial matrix,
and/or cellular uptake [35], does not measurably restrict its
Fig. 4 3D scans yield the tumescent skin profile over time. Panels (b) and (c) are lineouts of the full 3D data, shown immediately before (red) and after (black) a
20 mL injection in panel a). Dots in two perpendicular bands centered on X or Y=0 along the tumescent surface in (a) are shown in blue to help guide the eye.
The difference between the skin surface at various times after the injection, with that before the injection, is used to calculated the tumescent height and cross-
sectional area at half-height plotted in (d). Panels e) and (f) are contour plots of the difference at times t = 0 and t = 19min respectively. The process shown here is
the flow within the interstitial matrix immediately following injection, which results in a dense distribution of the injected fluid and additives throughout the
tumescent volume.
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motion and that it was carried with the saline. Since the dime-
sions of the iohexol molecule are comparable to those of the
antibiotic Cefazolin, we expect Cefazolin to spread similarly.
Based on these findings, we propose treating skin infections or
chronic wounds that extend into subcutaneous tissue with tar-
geted antibiotic injections directly into the affected tissue.
Chronic wounds are by definition those which have not
responded to traditional therapy and last for prolonged
lengths of time. The most common types fall into four catego-
ries: diabetic ulcers, pressure ulcers, venous ulcers, and arterial
ulcers. One hallmark of most chronic wounds is persistent,
runaway inflammation in which growth factors, cytokines,
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Fig. 5 CT coronal images in MIP mode showing the time evolution of various volume tumescent injections of saline with iodine contrast into abdominal
subcutaneous tissue of an adult Yucatán pig, both without a), and with b), 1:100000 epinephrine. Two injections each of 20 mL, 10 mL, 5 mL, and 2.5 mL were
done on left and right sides of the pig’s abdomen, with large volume injections closer to the pig’s head (top of images) and smaller ones towards the feet (bottom of
images). Images for t>4 hr. in (a) are not shown because the injections are difficult to see. The white dots along the center of the abdomen are markers placed in
the same axial plane as the injection location. White dots that form on the side of the tumescent spots in (b) are tumescent fluid that leaked out of the puncture
wounds. Lineouts crossing the center of the tumescent spots of a) and b) are shown in panel (c). Panel (d) shows the peak of the lineouts over time, indicating the
return of the tumescent tissue to normal. Epinephrine dramatically increases the fluid residence time in the tumesced tissue.
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immune cells, and other healing mediators are locked in an
imbalanced state that prevents healing [42–46]. Prolonged
attempts of wound closure lead to fibrin cuffs surrounding
capillaries that hinder cell migration, and the flow of nutrients,
healing mediators, and oxygen and to surrounding tissue
[47–50]. Infections, often resistant to antibiotics, contribute
to the bioburden and non-healing of wounds.
In choosing antibiotic dosage, there is a trade off between
minimizing systemic toxicity and effectively treating the infec-
tion. This balance can be optimized by keeping drug concen-
trations high at the infection only, which is what tumescent
antibiotic injections can provide. By keeping concentrations
low where they are not needed, systemic load is minimized.
With this technique, we estimate that drug concentrations at
the injection site can be increased by roughly the volume ratio
of the infection to the rest of the body (≤1000×) compared to
systemic delivery of the same dose, and infections that were
otherwise untreatable might become accessible. Antibiotics
that are likely to benefit from targeted delivery are those
whose minimum-inhibitory-concentration (MIC) is high
enough where toxicity is a concern if given systemically, but
low enough where the MIC can be reached with targeted
injections. For example, Methicillin-resistant Staphylococcus
aureus (MRSA) is an important pathogen commonly found
on both acute and chronic wounds [51, 52]. Silberg and
Nicolau [1] have demonstrated that nearly all of 1239 strains
of MRSA tested succumbed to Cefazolin at 512 mg L−1.
Comparable concentrations are achievable and tolerated [9,
19] with targeted injections. An important line of research will
be to identify the MIC of drug-resistant organisms to various
antibiotics to best plan treatment regiments.
Complicating factors in the treatment of chronic wounds
include the presence of biofilms, which are present in 60% of
chronic wounds, but only 10% of acute wounds [53].When the
bacterial density in a wound exceeds a threshold, bacteria that
are otherwise planktonic and mobile form polymicrobial colo-
nies and begin to act collectively [54]. Bacteria sense that their
density has reached critical through quorum sensing and begin
to express different genes [54]. They excrete exo-polymeric
substance, which forms the biofilm to house the microbes
[54]. The biofilm contains structures such as water channels
that bring in nutrients and carry away waste, and provides a
barrier to antimicrobial agents and immune cells [54].
Microbes in the biofilm become sessile and reduce their me-
tabolism, which reduces their susceptibility to antibiotics [54].
Tumescent antibiotic injections, when performed in con-
junction with sharp debridement and skin grafting as needed,
might be a safe and effective approach to treating deep skin
and soft-tissue infections, particularly chronic wounds, and
especially antibiotic-resistant ones. The volumetric expansion
of the affected tissue simultaneously addresses several core
issues of chronic wounds. It is the basis of 1) a dense distribu-
tion of antibiotic to infected tissue that is often inaccessible to
systemic dosing, 2) a dramatic increase in the hydraulic per-
meability and effective macromolecule diffusion constant in
regions with typically poor circulation, and 3) a fluid and
additive residence times of several hours.
Beyond keeping antibiotic concentrations high for a given
time duration, there may be other mechanisms by which tu-
mescent injections promote chronic wound healing. Further
experiments will probe whether the large volume infusions
and subsequent absorption also act to 4) structurally and
chemically disrupt biofilm, and/or 5) flush the imbalanced
inflammation mediators that result in the chronicity of the
wound and thereby reset the wound to an acute-like state.
Biofilm may not be as resilient to a 2− 4× volume expansion
as the extracellular matrix is, resulting in structural damage to
the film itself. The phenomenon of quorum sensing may be
disrupted by the saline flush as well as the increased average
interbacterial distance during the expansion, encouraging
bacteria to revert back to their planktonic state. As discussed,
wounds become chronic when natural healing mechanisms go
awry and become stuck in an imbalanced state. Flooding the
wound volume with fluid will necessarily dilute any inflamma-
tion and healing mediators and profoundly alter the local
microcirculation. Imbalanced mediators are flushed away
through the systemic absorption of the tumescent fluid via
the expanded interstitial network and circulation, and when
the tissue returns to its unexpanded state, the working point of
many nonlinear healing processes will be different. The flush-
ing strongly disturbs the balance of healing and inflammation
mediators and may act to reset the stuck, chronic healing
process to a new, healing-promoting state.
On the question of time duration required for concentrated
antibiotic to eradicate an infection, we offer some comments.
Since bacteriostatic drugs work by preventing the growth of
bacteria, we can estimate that that drug should remain con-
centrated for several bacteria division times. Doubling times
during the exponential-growth phase are 20–40 min for most
MRSA and other common strains [55, 56], and so a residence
time of a few hours satisfies this requirement. Bacteria in
chronic wounds, however, might not be in the exponential-
growth phase, so longer times may be needed. On the other
hand, bacteriostatic drugs often become bactericidal at high
concentrations [57], whereupon the doubling-time-scale is no
longer applicable. Further studies are needed to provide a
definitive answer.
As mentioned in the introduction, Silberg uses tumescent
antibiotic injections (4 mg mL−1 Cefazolin [9]) supplemented
with transcutaneous application of therapeutic ultrasound at
3W cm−2 to successfully treat chronic wounds, many of which
have antibiotic resistant infections. Therapeutic ultrasound
has recently been shown be ineffective at accelerating tumes-
cent fluid dispersal [58] or causing cavitation in tumescent
healthy tissue [59]. It may be that ultrasound is essential to
disperse the drug in inflamed tissue, enhance organism
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antibiotic susceptibility [60–62], or for some other reason.
However, given the physical picture we present, there is a
clinical possibility that the tumescent antibiotic injection is
effective on its own.
Our findings also have implications for systemic drug de-
livery. The pharmacokinetics of subcutaneously administered
drugs may be tailored by controlling injection volume and
vasoconstrictor concentration to form a tumescent drug depot
that is slowly released. When delivering large drugs such as
monoclonal antibodies, injection sites may be tumescently
primed to pre-expand the matrix before following with the
drug to prevent filtration and concentration of the large mol-
ecule near the needle. Although we did not investigate the use
of hyaluronidase to facilitate the spreading of tumescent injec-
tions [63], there is an opportunity to combine the techniques
to achieve more complex dynamics.
The ability of subcutaneous tissue to expand to a few times
its normal volume and recover safely [5] has been underap-
preciated by the medical community. We hope that by distill-
ing the unique properties and dynamics of the tumescent state,
this work stimulates discussion and focuses effort to fully real-
ize its therapeutic implications.
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